UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000012333
Receipt No. R000014421
Scientific Title Expression and functional analyses of immunoreceptors on human blood cells
Date of disclosure of the study information 2014/01/15
Last modified on 2016/06/21

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Expression and functional analyses of immunoreceptors on human blood cells
Acronym Functional analyses of human immunoreceptors
Scientific Title Expression and functional analyses of immunoreceptors on human blood cells
Scientific Title:Acronym Functional analyses of human immunoreceptors
Region
Japan

Condition
Condition none
Classification by specialty
Adult
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 1. To elucidate protein and gene expression of immunoreceptors on human blood cells.
2. To clarify the function of immunoreceptors by utilizing human primary blood cells and estimate the homology of the receptors between human and mouse.
3. To identify a novel immunoreceptor.
Basic objectives2 Others
Basic objectives -Others molecular biology, Basic research
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Expression and function of immunoreceptors on human blood cells. Identification of a novel immunoreceptor.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Healthy
Key exclusion criteria Unwilling to apply the study
Target sample size 300

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Akira Shibuya
Organization University of Tsukuba
Division name Department of Immunology, Division of Biomedical Science, Faculty of Medicine
Zip code
Address 1-1-1 Tennodai, Tsukuba Science-City, 305-8575, Japan
TEL 029-853-3281
Email ashibuya@md.tsukuba.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Satoko Tahara
Organization University of Tsukuba
Division name Department of Immunology, Division of Biomedical Science, Faculty of Medicine
Zip code
Address 1-1-1 Tennodai, Tsukuba Science-City, 305-8575, Japan
TEL 029-853-3281
Homepage URL
Email tokothr@md.tsukuba.ac.jp

Sponsor
Institute University of Tsukuba
Institute
Department

Funding Source
Organization Create revolutionary technological seeds for science and technology innovation (CREST), Japan science and technology agency (JST)
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 15 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2013 Year 11 Month 15 Day
Date of IRB
Anticipated trial start date
2014 Year 01 Month 16 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information We will analyze the expression and function of immunoreceptors by ELISA, FACS, WB, qPCR, and gene sequence method. We will also identify a novel immunoreceptor by gene cloning technics.

Management information
Registered date
2013 Year 11 Month 18 Day
Last modified on
2016 Year 06 Month 21 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014421

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.